Combes H J, Heinrich J
Frauenklinik des Bezirkskrankenhauses, Stralsund.
Zentralbl Gynakol. 1990;112(13):839-41.
36 patients with 432 menstrual cycles and primary dysmenorrhea were treated with Piroxicam-Jenapharm. Piroxicam-Jenapharm was given in a dose of 40 mg once daily for the first 2 days followed by 20 mg once daily. Piroxicam, a nonsteroidal-anti-inflammatory drug (NSAID) is an effective drug in reducing menstrual pain intensity in 80%. Piroxicam was well tolerated with no patient reporting side-effects. The treatment of primary dysmenorrhea with total 100 mg Piroxicam-Jenapharm over 3 days is recommended.
36例患有432个月经周期且原发性痛经的患者接受了萘普生-耶拿制药公司生产的吡罗昔康治疗。吡罗昔康-耶拿制药公司生产的吡罗昔康给药剂量为,前2天每日40毫克,之后每日20毫克。吡罗昔康是一种非甾体抗炎药(NSAID),是一种能有效减轻80%的痛经强度的药物。吡罗昔康耐受性良好,没有患者报告有副作用。建议用总量100毫克的吡罗昔康-耶拿制药公司生产的吡罗昔康在3天内治疗原发性痛经。